Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 5, 2008, Pages

  Trask, Aaron J ^a   Jessup, Jewell A ^a   Chappell, Mark C ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin (1 7); Angiotensinogen; Hypertension; Renin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II; ANGIOTENSIN[1-12]; ANGIOTENSIN[1-7]; ANGIOTENSINOGEN; UNCLASSIFIED DRUG; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); PEPTIDE FRAGMENT; PROANGIOTENSIN 12, RAT; PROANGIOTENSIN-12, RAT; REN2 PROTEIN, MOUSE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART; HEART PERFUSION; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RAT STRAIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; DISEASE MODEL; GENETICS; HEART MUSCLE; HYPERTENSION; LEWIS RAT; METABOLISM; PERFUSION; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; TIME; TRANSGENIC ANIMAL; WISTAR KYOTO RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; ANGIOTENSINS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; MYOCARDIUM; PEPTIDE FRAGMENTS; PERFUSION; RATS; RATS, INBRED LEW; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RENIN; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS;

EID: 44949253157     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00175.2008     Document Type: Article

References (18)

1. Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension 50: 596-599, 2007.
2. Chappell MC, Gallagher PE, Averill DB, Ferrario CM, Brosnihan KB. Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2.Lewis rat. Hypertension 42: 781-786, 2003.
3. Chappell MC, Westwood BM, Pendergrass KD, Jessup JA, Ferrario CM. Distinct processing pathways for the novel peptide angiotensin-(1-12) in the serum and kidney of the hypertensive mRen2.Lewis rat (Abstract). Hypertension 50: e139, 2007.
4. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111: 2605-2610, 2005.
5. Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann TE, Smith RD, Chappell MC. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int 68: 2189-2196, 2005.
6. Jessup JA, Chappell MC, Nagata S, Kato J, Kitamura K, Ferrario CM. Localization of the novel angiotensin peptide, proangiotensin-12, in the heart and kidney of hypertensive and normotensive rats (Abstract). Hypertension 50: e101, 2007.
7. Lindpaintner K, Jin MW, Niedermaier N, Wilhelm MJ, Ganten D. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ Res 67: 564-573, 1990.
8. Mendelsohn FA, Johnston CI. A radiochemical renin assay. Biochem J 121: 241-244, 1971.
9. Montague D, Riniker B, Brunner H, Gross F. Synthesis and biological activities of a tetradecapeptide renin substrate. Am J Physiol 210: 591-594, 1966.
10. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun 350: 1026 -1031, 2006.
11. Nakamura S, Averill DB, Chappell MC, Diz DI, Brosnihan KB, Ferrario CM. Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. Am J Physiol Regul Integr Comp Physiol 284: R164-R173, 2003.
12. Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. Lancet 370: 221-229, 2007.
13. Skeggs LT Jr, Lentz KE, Kahn JR, Shumway NP. The synthesis of a tetradecapeptide renin substrate. J Exp Med 108: 283-297, 1958.
14. Tigerstedt R, Bergman PG. Niere und Kreislauf. Scan Arch Physiol 8: 223-271, 1898.
15. Trask AJ, Averill DB, Ganten D, Chappell MC, Ferrario CM. Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats. Am J Physiol Heart Circ Physiol 292: H3019-H3024, 2007.
16. Trask AJ, Jessup JA, Ferrario CM. Angiotensin-(1-12) is a precursor for the processing of cardiac tissue angiotensin peptides (Abstract). Hypertension 50: e154. 2007.
17. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 52: 1461-1480, 1993.
18. Zisman LS, Meixell GE, Bristow MR, Canver CC. Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate. Circulation 108: 1679-1681, 2003.